Mr. Sachin Aggarwal reports

THINK RESEARCH ANNOUNCES DATE OF THIRD QUARTER AND YEAR-TO-DATE 2023 RESULTS AND CONFERENCE CALL DETAILS

Think Research Corp. will release third quarter 2023 results premarket, Monday, Nov. 27, 2023. Think's financial statements and management discussion and analysis will be available under the company's profile on SEDAR+ and on the company's website as of 7 a.m. Eastern Time.

Subsequently, chief executive officer Sachin Aggarwal and chief financial officer John Hayes with host a conference call to discuss the results, with a Q&A (question-and-answer) session to follow.

Time:  8:30 a.m. ET, Monday, Nov. 27, 2023

Conference call participant details:

Canada/U.S. toll-free:  1-800-319-4610

International toll:  1-604-638-5340

About Think Research Corp.

Think Research is an industry leader in delivering knowledge-based digital health software solutions. The company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based health care technology solutions support the clinical decision-making process and standardization of care to facilitate better health care outcomes. The company gathers, develops and delivers knowledge-based solutions globally to customers, including enterprise clients, hospitals, health regions, health care professionals and/or governments. The company has gathered a significant amount of data by building its repository of knowledge through its network and group of companies.

Think Research licenses its solutions to over 14,200 facilities for over 320,000 primary care, acute care and long-term-care doctors, nurses and pharmacists who rely on the content and data provided by Think Research to support their practices. Millions of patients and residents annually receive better care due to the essential data that Think Research produces, manages and delivers.

In addition, the company collects and manages pharmaceutical and clinical trial data through its BioPharma Services subsidiary. BioPharma Services is a leading provider of bioequivalence and phase 1 clinical research services to pharmaceutical companies globally. Think Research's other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery.